Skip links

Epilepsy: Our Immediate Focus

Around 50 million people worldwide struggle with epilepsy, making it one of the most common neurological diseases globally.

1 in every 3 Patients are untreatable with medication.

“Novela is currently collaborating with Universities, Hospitals and Institutions to develop effective treatments and stop dangerous seizures from occurring. We believe we will have a human medical treatment in the next 24 months”

Ray Iskander, Novela CEO

How Epilepsy is Treated with Neureka™

When an oncoming seizure is detected our interface sends a tiny electric current instructing the brain to stop the seizure before it occurs. In a successful collaboration with the Hospital for Sick Children in Toronto, we were able to predict and prevent seizures with high level of accuracy using neuromodulation.

Investigating Epilepsy with Neureka™

Novela’s EEG Module detects seizures before they occur and captures data that accelerates development of Dynamiceutical treatments and predictive markers for Sudden Unexpected Death in Epilepsy (SUDEP)